These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37815053)

  • 1. Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank.
    Jin D; Trichia E; Islam N; Bešević J; Lewington S; Lacey B
    J Am Heart Assoc; 2023 Oct; 12(20):e029552. PubMed ID: 37815053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
    Björnson E; Adiels M; Taskinen MR; Burgess S; Rawshani A; Borén J; Packard CJ
    Eur Heart J; 2023 Oct; 44(39):4186-4195. PubMed ID: 37358553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein.
    Koba S; Hirano T; Sakaue T; Takeuchi H; Adachi M; Katagiri T
    Coron Artery Dis; 2002 Aug; 13(5):255-62. PubMed ID: 12394649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.
    Deng K; Pan XF; Voehler MW; Cai Q; Cai H; Shu XO; Gupta DK; Lipworth L; Zheng W; Yu D
    J Am Heart Assoc; 2024 May; 13(10):e034364. PubMed ID: 38726919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of circulating fatty acids with incident coronary heart disease: a prospective study of 89,242 individuals in UK Biobank.
    Jin D; Trichia E; Islam N; Lewington S; Lacey B
    BMC Cardiovasc Disord; 2023 Jul; 23(1):365. PubMed ID: 37480048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
    Tornvall P; Karpe F; Carlson LA; Hamsten A
    Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
    Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
    Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
    Freedman DS; Otvos JD; Jeyarajah EJ; Shalaurova I; Cupples LA; Parise H; D'Agostino RB; Wilson PW; Schaefer EJ
    Clin Chem; 2004 Jul; 50(7):1189-200. PubMed ID: 15107310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults.
    Haslam DE; Chasman DI; Peloso GM; Herman MA; Dupuis J; Lichtenstein AH; Smith CE; Ridker PM; Jacques PF; Mora S; McKeown NM
    J Nutr; 2022 Nov; 152(11):2534-2545. PubMed ID: 36774119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.
    Steffen BT; Guan W; Remaley AT; Paramsothy P; Heckbert SR; McClelland RL; Greenland P; Michos ED; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):448-54. PubMed ID: 25477346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
    Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.
    Geng TT; Chen JX; Lu Q; Wang PL; Xia PF; Zhu K; Li Y; Guo KQ; Yang K; Liao YF; Zhou YF; Liu G; Pan A
    Am J Kidney Dis; 2024 Jan; 83(1):9-17. PubMed ID: 37678743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).
    Mackey RH; Greenland P; Goff DC; Lloyd-Jones D; Sibley CT; Mora S
    J Am Coll Cardiol; 2012 Aug; 60(6):508-16. PubMed ID: 22796256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.